CRISPR Therapeutics AG Cash and Cash Equivalents 2011-2026 | CRSP

Annual Cash and Cash Equivalents CRISPR Therapeutics AG

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
348 M	298 M	389 M	212 M	923 M	1.17 B	944 M	457 M	240 M	316 M	156 M	945 K	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.17 B	945 K	454 M

Quarterly Cash and Cash Equivalents CRISPR Therapeutics AG

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
286 M	194 M	235 M	298 M	226 M	484 M	707 M	389 M	528 M	445 M	344 M	212 M	494 M	497 M	684 M	923 M	1.01 B	1.65 B	1.13 B	1.17 B	1.17 B	1.17 B	1.17 B	944 M	944 M	944 M	944 M	457 M	457 M	457 M	457 M	240 M	254 M	272 M	289 M	316 M	316 M	316 M	316 M	156 M	156 M	-	-	945 K	-	-	-	361 K	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.65 B	361 K	550 M

Cash and Cash Equivalents of other stocks in the Biotechnology industry

Issuer	Cash and Cash Equivalents	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	158 M	-	2.43 %	$ 254 M	Germany
Aeglea BioTherapeutics AGLE	85.7 M	-	-	$ 1.01 B	USA
I-Mab IMAB	4.76 B	-	-	$ 866 M	China
Midatech Pharma plc MTP	8.53 M	-	-18.52 %	$ 27.3 M	Britain
AIkido Pharma AIKI	34 M	-	1.93 %	$ 17.4 M	USA
Nymox Pharmaceutical Corporation NYMX	830 K	-	-19.68 %	$ 18.4 M	Canada
Aptorum Group Limited APM	3.5 M	$ 0.9	-2.33 %	$ 6.62 M	China
Biophytis SA BPTS	5.57 M	-	-13.47 %	$ 169 M	France
Genfit SA GNFT	81.8 M	-	2.54 %	$ 160 B	France
ACADIA Pharmaceuticals ACAD	320 M	$ 21.96	-0.68 %	$ 3.64 B	USA
RedHill Biopharma Ltd. RDHL	4.62 M	$ 1.02	-0.49 %	$ 428 M	Israel
Allakos ALLK	66.4 M	-	-	$ 28.6 M	USA
Advaxis ADXS	4.88 M	-	-9.65 %	$ 45.9 M	USA
AlloVir ALVR	98.1 M	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	4.09 M	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	61.1 M	-	-	$ 10.1 M	USA
Akouos AKUS	122 M	-	0.23 %	$ 488 M	USA
Aligos Therapeutics ALGS	18.3 M	$ 6.4	4.4 %	$ 63.3 M	USA
Applied Therapeutics APLT	49.9 M	-	-	$ 8.42 M	USA
Aptinyx APTX	56.2 M	-	-39.0 %	$ 4.57 M	USA
Aridis Pharmaceuticals ARDS	4.88 M	-	17.91 %	$ 11.1 M	USA
Avenue Therapeutics ATXI	2.86 M	-	-52.27 %	$ 4.45 M	USA
Amphastar Pharmaceuticals AMPH	170 M	$ 21.41	1.9 %	$ 1 B	USA
Aravive ARAV	53.7 M	-	-13.39 %	$ 1.45 M	USA
AstraZeneca PLC AZN	5.71 B	-	-	$ 96.9 B	Britain
BioDelivery Sciences International BDSI	112 M	-	-4.8 %	$ 255 M	USA
Aeterna Zentaris AEZS	7.31 M	-	5.93 %	$ 314 M	Canada
Brainstorm Cell Therapeutics BCLI	29 K	-	-2.5 %	$ 5.88 M	USA
Kazia Therapeutics Limited KZIA	7.36 M	$ 12.26	3.72 %	$ 1.62 B	Australia
AgeX Therapeutics AGE	3.06 M	-	-10.17 %	$ 12.2 K	USA
BioNTech SE BNTX	7.68 B	$ 105.46	-0.09 %	$ 27.2 B	Germany
BeiGene, Ltd. BGNE	4.55 B	-	0.49 %	$ 251 B	Cayman-islands
Ayala Pharmaceuticals AYLA	2.41 M	-	-	$ 7.46 M	Israel
Applied Genetic Technologies Corporation AGTC	46.4 M	-	-	$ 26.5 M	USA
Aquestive Therapeutics AQST	121 M	$ 4.08	0.25 %	$ 436 M	USA
Arcutis Biotherapeutics ARQT	42.9 M	$ 23.26	1.75 %	$ 2.96 B	USA
Cara Therapeutics CARA	20.7 M	-	-3.03 %	$ 260 M	USA
Autolus Therapeutics plc AUTL	104 M	$ 1.44	-5.88 %	$ 383 M	Britain
Aptose Biosciences APTO	935 K	-	-45.71 %	$ 1.2 M	Canada
BioXcel Therapeutics BTAI	28.4 M	$ 1.06	-3.64 %	$ 12.9 M	USA
CASI Pharmaceuticals CASI	38.7 M	-	-	$ 35.4 M	USA
AVROBIO AVRO	98 M	-	1083.1 %	$ 745 M	USA
Cabaletta Bio CABA	83 M	$ 2.95	-3.28 %	$ 296 M	USA
Can-Fite BioPharma Ltd. CANF	8.27 M	$ 2.91	-1.36 %	$ 4.79 M	Israel
bluebird bio BLUE	222 M	-	-	$ 546 M	USA
CymaBay Therapeutics CBAY	207 M	-	-	$ 3.45 B	USA
Akero Therapeutics AKRO	340 M	-	-	$ 3.67 B	USA